07:13 AM EDT, 10/30/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q3 earnings Wednesday of $6.39 per diluted share, up from $5.38 a year earlier.

Analysts polled by Capital IQ expected $6.42.

Revenue for the quarter ended Sept. 30 was $748.9 million, compared with $609.4 million a year earlier.

Analysts polled by Capital IQ expected $722.8 million.

Price: 354.75, Change: +2.17, Percent Change: +0.62